Locally advanced non-small cell lung cancer - Pretreatment prognostic factors: Disease stage, tumor histopathological characteristics, the patient-related factors

Archive of Oncology

Volumn 15, Issue 1-2, 2007, Pages 19-23

  Vasić, Ljiljana ^a,b  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b Bukureška 13 ^*  (Serbia)

Author keywords

Age factors; Carcinoma; Comorbidity; Karnofsky performance status; Neoplasm staging; Neoplasms by histologic type; Non small cell lung; Prognosis; Psychomotor performance; Sex factor

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARDIOMYOPATHY; COMORBIDITY; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOMOTOR PERFORMANCE; SEX RATIO;

EID: 36849043140     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0702019V     Document Type: Article

References (26)

1. th, 2002. Available from http://www.uicc.org
2. Maki E, Feld R. Prognostic factors in patients with non-small cell lung cancer. A critique of the world literature. Lung Cancer 1991;7:27-34.
3. Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, et al. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys 2000;48:1475-82.
4. Bailar JC III, Mosteller F. Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 1988;108:266-73.
5. Dželatović A. Rezultati globalnog istrazivanja upotrebe duvana u Srbiji. Rak 2004;52:5-6.
6. Noncommnicable diseases in the WHO European Region: the challenge. WHO-Europe, Copenhagen 2004. Available from http://www.euro.who.int/mediacentre
7. Trends in Lung Cancer Morbidity and Mortality. American Lung Association Epidemiology and Statistics Unit Research and Scatistic Affairs, 2004. Available from http://who.int/topics/cancer
8. Solan MJ, Werner-Wasik M. Prognostic factors in non-small cell lung cancer. Semin Surg Oncol 2003;21:64-73.
9. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980;65:25-32.
10. Takigawa N, Segawa Y, Okahara M, Maeda Y, Takata I, Kataoka M, et al. Prognostic factors for patients with advanced non-small lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 1996;15:67-77.
11. Minami Y, Matsuno Y, Iijima T, Morishta Y, Onizuka M, Sakakibara Y, et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer 2005;48:339-48.
12. Mountain CF, Lukeman JM, Hammar SP, Chamberlain DW, Coulson WF, Page DL, et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 1987;35:147-56.
13. Križanac Š. Patologija i biologija U: Šamija M, Tomek R, Pavelić Lj, editors. Rak pluća. Zagreb: Nakladni zavod Globus; 1988. p. 107-24.
14. Bernasconi NL, Wormhoudt TA, Laird-Offringa A. Post-transcriptional deregulation of myc genes in lung cancer cell lines. Am J Respir Cell Mol Biol 2000;23:560-5.
15. Vattemi E, Claudio PP. Gene therapy for lung cancer: practice and promise. Ann Ital Chir 2004;75:279-89.
16. WAF-1 proteins in carcinogenesis of bronchial mucosa. Pneumon 1999;12:91-101.
17. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622-6.
18. Langer CJ, Manola J, Bernardo P. Advanced age alone does not compromise outcome in fit non-small cell lung cancer patients receiving platinum-based therapy. ASCO Annual Meeting 36rd. New Orleans 2000. Available from http://www.asco.org/portal/site
19. Ginsberg R, Vokes E, Rosenzweig K. Non-small lung cancer. In: DeVitta VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology, Philadelphia: Lippnicot-Wiliams & Wilkins; 2001. p. 688.
20. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine 1990;69:1-33.
21. Paci M, Sgarbi G, Ferrari G, De Franco S, Annesi V. Controversies over UICC-TNM classification of non-small lung cancer: model for a diagnostic path. Chest 2002:122:754.
22. Jeremic B, Shibamoto Y. Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy. Lung Cancer 1995;13:21-30.
23. Brundage M, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-57.
24. Chang MY, Sugarbaker DJ. Surgery for early stage non-small cell lung cancer. Semin Surg Oncol 2003;21:74-84.
25. Grunenwald D. Surgery for locally advanced non-small cell lung cancer. Semin Surg Oncol 2003;21:85-90.
26. Barbera L, Walker H, Foroudi F, Tyldesley S, Mackillop W. Estimating the benefit and cost of radiotherapy for lung cancer. Int J Technol Assess Health Care 2004;20:545-51.